Molecular pathology of malignant gliomas
DN Louis - Annu. Rev. Pathol. Mech. Dis., 2006 - annualreviews.org
Malignant gliomas, the most common type of primary brain tumor, are a spectrum of tumors
of varying differentiation and malignancy grades. These tumors may arise from neural stem …
of varying differentiation and malignancy grades. These tumors may arise from neural stem …
Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme
Introduction: Research into the pathogenesis, molecular signaling, and treatment of
glioblastoma multiforme (GBM) has traditionally been conducted using cell lines derived …
glioblastoma multiforme (GBM) has traditionally been conducted using cell lines derived …
[HTML][HTML] Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing
AH Martínez, R Madurga, N García-Romero… - Cancer letters, 2022 - Elsevier
Glioblastoma (GBM) is the most invasive and deadliest brain cancer in adults. Its inherent
heterogeneity has been designated as the main cause of treatment failure. Thus, a deeper …
heterogeneity has been designated as the main cause of treatment failure. Thus, a deeper …
[HTML][HTML] Metabolic/proteomic signature defines two glioblastoma subtypes with different clinical outcome
Glioblastoma (GBM) is one of the deadliest human cancers. Because of the extremely
unfavorable prognosis of GBM, it is important to develop more effective diagnostic and …
unfavorable prognosis of GBM, it is important to develop more effective diagnostic and …
Protein patterns and proteins that identify subtypes of glioblastoma multiforme
M Furuta, RJ Weil, AO Vortmeyer, S Huang, J Lei… - Oncogene, 2004 - nature.com
Glioblastoma multiforme (GBM) has been subdivided into two types based on clinical and
genetic findings: primary tumors, which arise de novo, and secondary tumors, which …
genetic findings: primary tumors, which arise de novo, and secondary tumors, which …
[HTML][HTML] Decipher the glioblastoma microenvironment: the first milestone for new groundbreaking therapeutic strategies
GN Fanelli, D Grassini, V Ortenzi, F Pasqualetti… - Genes, 2021 - mdpi.com
Glioblastoma (GBM) is the most common primary malignant brain tumour in adults. Despite
the combination of novel therapeutical approaches, it remains a deadly malignancy with an …
the combination of novel therapeutical approaches, it remains a deadly malignancy with an …
Clinical impact of molecular biomarkers in gliomas
T Siegal - Journal of Clinical Neuroscience, 2015 - Elsevier
Abstract The World Health Organization (WHO) classification system for glial tumors
provides guidance as to the predicted course of the disease and choice of treatment …
provides guidance as to the predicted course of the disease and choice of treatment …
A molecular genetic model of astrocytoma histopathology
DN Louis - Brain pathology, 1997 - Wiley Online Library
As the molecular events responsible for astrocytoma formation and progression are being
clarified, it is becoming possible to correlate these alterations with the specific …
clarified, it is becoming possible to correlate these alterations with the specific …
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone
JM Lemée, A Clavreul, P Menei - Neuro-oncology, 2015 - academic.oup.com
Glioblastoma (GB) is the most frequent and aggressive primary tumor of the central nervous
system. Prognosis remains poor despite ongoing progress. In cases where the gadolinium …
system. Prognosis remains poor despite ongoing progress. In cases where the gadolinium …
Genetics of glioblastoma: a window into its imaging and histopathologic variability
Glioblastoma is a highly malignant brain tumor that relentlessly defies therapy. Efforts over
the past decade have begun to tease out the biochemical details that lead to its aggressive …
the past decade have begun to tease out the biochemical details that lead to its aggressive …